Cerebral venous thrombosis due to heparin-induced thrombocytopenia

dc.contributor.authorKyritsis, A. P.en
dc.contributor.authorWilliams, E. C.en
dc.contributor.authorSchutta, H. S.en
dc.date.accessioned2015-11-24T19:31:10Z
dc.date.available2015-11-24T19:31:10Z
dc.identifier.issn0039-2499-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/23219
dc.rightsDefault Licence-
dc.subject*Cerebral Veinsen
dc.subjectFemaleen
dc.subjectHeparin/*adverse effects/therapeutic useen
dc.subjectHumansen
dc.subjectMiddle Ageden
dc.subjectPlatelet Aggregation/drug effectsen
dc.subjectPolycythemia Vera/*complicationsen
dc.subjectThrombophlebitis/complications/*therapyen
dc.subjectThrombosis/blood/*chemically induceden
dc.titleCerebral venous thrombosis due to heparin-induced thrombocytopeniaen
heal.abstractA patient with polycythemia vera who was treated with heparin for superficial septic thrombophlebitis developed heparin-induced thrombocytopenia and cerebral venous thrombosis with superior sagittal sinus occlusion 11 days after the institution of heparin therapy. We suggest that the severe thrombotic response to the heparin-induced platelet disorder in this patient occurred because the polycythemia vera and the purulent infection enhanced the thrombophilia caused by heparin-induced thrombocytopenia. This condition can be avoided in most instances if heparin is used for no longer than 5 days.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/2219218-
heal.journalNameStrokeen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate1990-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: